Philip Vickers, Founder of Faze Medicines

Philip Vickers is the founder of Faze Medicines. Faze Medicines has raised $81M in total funding. Latest round: Series A. Based in Cambridge, USA.

About Philip Vickers

Philip Vickers, Ph.D., is the Co-founder and former CEO of Faze Medicines, a biotechnology startup founded in 2020 that developed therapies targeting biomolecular condensates. The company launched with an $81 million Series A round in December 2020 but quietly shut down in 2022. Vickers is currently the President and CEO of Solu Therapeutics.

Philip Vickers at a glance

More founders in Cambridge, USA (44)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library